Lovo-cel

· Genetix Biotherapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lovo-cel, covering 2024-10-08 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease [Phase 1, Phase 2]